A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS

NCT01864005 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-ST or ST Elevation Acute Coronary Syndromes

Interventions

DRUG: Ticagrelor
DRUG: Clopidogrel

Sponsor

AstraZeneca